|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
10.08 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
10.29 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
11.09 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Head of Marketing/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
7³â¡è |
ä¿ë½Ã |
10.13 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Medical Team Manager/Èñ±ÍÁúȯFranchise(±¹³» »óÀ§±ÇÀÇ Á¦
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
7³â¡è |
ä¿ë½Ã |
01.13 |
|
|
¿¡½º¿¥¾ÆÀÌ |
Validation
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
7³â¡è |
ä¿ë½Ã |
03.11 |
|
|
JN Partners |
¼ÕÀÍ/¿ø°¡ 7³â ÀÌ»ó
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
7³â¡è |
ä¿ë½Ã |
09.18 |
|
|
JN Partners |
[±¹³»Á¦¾à»ç] ÀÓ»óÆÀÀå 2°³ Æ÷Áö¼Ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
7³â¡è |
ä¿ë½Ã |
06.25 |
|
|
JN Partners |
[Á¦¾à»ç] ÇØ¿ÜRAÆÀÀå
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
7³â¡è |
ä¿ë½Ã |
08.24 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
»óÀåÁ¦¾à»ç ÀÓ»óPM(7³âÀÌ»ó)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
03.15 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
»óÀåÁ¦¾à»ç ÀÓ»óÆÀ(7³âÀÌ»ó)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
09.28 |
|
|
HRKorea |
»ç¾÷ ±âȹ Á¤ºÎ°úÁ¦¸Å´ÏÀú ÆÀÀå- ÀÇ·á±â±â ȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
6³â¡è |
ä¿ë½Ã |
09.25 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Therapy Advancement Manager(CRM)/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
11.21 |
|
|
¿¡¹öºê·¹ÀÎÄÁ¼³Æà |
[½Å±Ô»ç¾÷ºÎ]½Ã´Ï¾îÄÉ¾î ½Å±Ô»ç¾÷±âȹ ´ë¸® °úÀå±Þ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
6³â¡è |
ä¿ë½Ã |
11.23 |
|
|
ÈÞ¸ÕµðÁöÅ» |
Image(Signal) Processing Àü¹®°¡
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÇìµåÇåÅÍ |
6³â¡è |
ä¿ë½Ã |
02.13 |
|